Navigation Links
HeartWare International Reports First Quarter 2011 Revenues of $18.0 Million; 68% Increase From $10.7 Million in First Quarter 2010
Date:5/5/2011

FRAMINGHAM, Mass. and SYDNEY, May 5, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenues of $18.0 million for the first quarter ended March 31, 2011.  This represents a 68 percent increase from $10.7 million in revenues for the first quarter of 2010.

"During the first quarter, we generated our second highest international sales results for the HeartWare® Ventricular Assist System.  We are appreciative of the strong support of our 56 customers in 18 countries, as 134 pumps were sold outside of the U.S.," explained Doug Godshall, President and Chief Executive Officer.  "The international markets accounted for 65 percent of our revenues, or approximately $11.7 million for the 2011 first quarter, up from $8.0 million in the first quarter of 2010."

"In the U.S., where first quarter revenues more than doubled to $6.3 million compared to $2.7 million in the first quarter of 2010, we now have 46 of the planned 50 U.S. sites approved for implantation in our 450-patient destination therapy study, and 121 patients have been randomized and enrolled," added Mr. Godshall.  "In the first quarter, we also received our largest allotment – 94 patients – granted by the Food and Drug Administration (FDA) in January under the Continued Access Protocol (CAP) for our bridge-to-transplant clinical study.  Participating hospital sites began the re-initiation process and have enrolled 28 patients in this third CAP cohort."

Total operating expenses for the first quarter of 2011 were $18.0 million, compared to $9.3 million in the prior year period.  Research and development expense was $9.3 million for the first quarter of 2011, primari
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Presentation of HeartWare Clinical Results
2. HeartWare International Clinical Trial Shows 90% Survival at 180 Days
3. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
4. HeartWare International Reports Third Quarter Revenues of $7.5 Million
5. HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City
6. HeartWare to Present at the UBS 2010 Global Life Sciences Conference
7. HeartWare to Present at Lazard Capital Markets Circulatory Assist Device Day
8. HeartWare to Report Financial Results for Third Quarter of 2010
9. HeartWare International Reports Third Quarter 2010 Revenues of $13.8 Million; Compared to $7.5 Million in Third Quarter of 2009
10. HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
11. HeartWare to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 2014 /PRNewswire-iReach/ -- ChemImage founder and CTO, Patrick ... describing an innovative diagnostic procedure for the detection of ... on Disease (SPEC) conference in Krakow, Poland ... "Development of in vitro Diagnostics for Detection of Colorectal ... the conference poster session on Tuesday, August 19, 2014 ...
(Date:8/19/2014)... 2014  As power morcellator lawsuits continue to ... LLP notes that women in need of fibroid ... of options that do not involve the use ... a report published by The Wall Street Journal ... a mini-laparotomy and vaginal hysterectomy. Non-surgical options for ...
(Date:8/19/2014)... Research and Markets has announced the addition of the ... report to their offering. This report ... US$ Million by the following Brands: Humatrope, Norditropin, Genotropin, Nutropin, ... analytics for the US, Canada , ... Asia-Pacific , and Rest of World. Annual estimates ...
Breaking Medicine Technology:ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Global Human Growth Hormone Drugs - Strategic Business Report 2014 2
(Date:8/20/2014)... (PRWEB) August 20, 2014 Biosimilars, ... that are approved through an abbreviated process, could ... issue of Atlantic Information Services, Inc.’s (AIS) Specialty ... this segment, including the Food and Drug Administration’s ... first step towards approval. , Drugmaker Sandoz said ...
(Date:8/20/2014)... Ticketability.com has Theresa Caputo tickets ... The well-known medium has been thrilling many with her ... 19 cities, with tickets becoming available August 15. , ... are Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, Charlotte, Houston, ... San Diego. The medium’s fans can obtain Theresa Caputo ...
(Date:8/20/2014)... people grow older, they often have difficulty falling asleep ... in the morning. In individuals with Alzheimer,s disease, this ... especially pronounced, often leading to nighttime confusion and wandering. ... Israel Deaconess Medical Center (BIDMC) and the University of ... more fragmented with age. Reported online today in the ...
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 At this ... of Africa. To help eliminate the root cause of the ... recently teamed up with the nonprofit organization Books For Africa ... Africans: How Every African Can Live the Life of Their ... , This book equips Africans with the tools they need ...
(Date:8/20/2014)... August 20, 2014 This agreement ... of software defined networking, high availability cloud enablement, ... of Resellers, while allowing OPEN-V to sell storageFOUNDRY’s ... pleased to work with OPEN-V on this distribution ... Hows, manager distribution channels at storageFOUNDRY. "Nautilus is ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:Ebola, Poverty, and a Partnership for Africa—How Everyone Can Help 2Health News:Ebola, Poverty, and a Partnership for Africa—How Everyone Can Help 3Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 3
... MONDAY, Oct. 31 (HealthDay News) -- Construction workers in the ... an increased risk of work-related illness and death, a new ... and found that a construction worker has a 75 percent ... and a 1-in-200 risk of being fatally injured on the ...
... Certain factors unique to professional sports can increase the risk ... staff, a new report suggests. Norovirus is the most ... and causes 21 million cases of illness in the United ... 31 online edition of the journal Clinical Infectious Diseases ...
... Just two extra hours of focused training significantly increased ... polyps , known as adenomas, in the colon, according ... These findings suggest that new methods to educate endoscopists, ... colorectal cancer detection rates and potentially reduce cancer ...
... a 2010 outbreak involving several NBA teams, the ... a professional sports association. Published in Clinical ... ), the study highlights unique circumstances for spreading ... on and off the court. Norovirus ...
... forms of birth control are vastly different from those ... levels of hormones and with different means of delivery ... problems related to women,s pleasure remain. An ... hormonal contraception affect things such as arousal, lubrication and ...
... (October 30 2011)In a technical tour de force, scientists ... the actions of 178 candidate drugs capable of blocking ... including enzymes critical for cancer and other diseases. Additionally, ... available online to the research community. This unique library ...
Cached Medicine News:Health News:'Hard Hats' Still Have High Rates of Injury, Illness: Report 2Health News:Stomach Bug Easily Passed Among Pro Sports Teams: Report 2Health News:Mayo Clinic: Short training course significantly improves detection of precancerous polyps 2Health News:Mayo Clinic: Short training course significantly improves detection of precancerous polyps 3Health News:NBA players not immune to serious illness from norovirus 2Health News:Not your mother's birth control, same troubles 2Health News:First-of-its-kind study creates new tool for targeted cancer drug development 2Health News:First-of-its-kind study creates new tool for targeted cancer drug development 3
... anterior cervical plate system is the lowest ... height includes an integrated lock mechanism, which ... bone screws. Surgeons appreciate the narrow width, ... dissection required. The system also offers easy ...
... been providing excellence in Ambulatory ECG ... of physicians in the diagnosis and ... conditions each year. State-of-the-art equipment and ... the highest standard of customer service ...
... incubator is an extremely compact and ... microplate up to 50C. ,Solo ... higher temperatures up to 65C. Solo ... cost and high performance for varied ...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Medicine Products: